PSNL
Price
$5.21
Change
+$0.15 (+2.96%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
75.25M
61 days until earnings call
XRAY
Price
$15.95
Change
+$0.04 (+0.25%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
6.69B
55 days until earnings call
Interact to see
Advertisement

PSNL vs XRAY

Header iconPSNL vs XRAY Comparison
Open Charts PSNL vs XRAYBanner chart's image
Personalis
Price$5.21
Change+$0.15 (+2.96%)
Volume$4.97K
Capitalization75.25M
DENTSPLY SIRONA
Price$15.95
Change+$0.04 (+0.25%)
Volume$33.2K
Capitalization6.69B
PSNL vs XRAY Comparison Chart
Loading...
PSNL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PSNL vs. XRAY commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSNL is a Hold and XRAY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (PSNL: $5.06 vs. XRAY: $15.89)
Brand notoriety: PSNL and XRAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PSNL: 139% vs. XRAY: 57%
Market capitalization -- PSNL: $75.25M vs. XRAY: $6.69B
PSNL [@Medical Specialties] is valued at $75.25M. XRAY’s [@Medical Specialties] market capitalization is $6.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PSNL’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • PSNL’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, PSNL is a better buy in the long-term than XRAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PSNL’s TA Score shows that 5 TA indicator(s) are bullish while XRAY’s TA Score has 5 bullish TA indicator(s).

  • PSNL’s TA Score: 5 bullish, 5 bearish.
  • XRAY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both PSNL and XRAY are a good buy in the short-term.

Price Growth

PSNL (@Medical Specialties) experienced а +10.24% price change this week, while XRAY (@Medical Specialties) price change was -2.69% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.10%. For the same industry, the average monthly price growth was +5.39%, and the average quarterly price growth was +1.86%.

Reported Earning Dates

PSNL is expected to report earnings on Aug 06, 2025.

XRAY is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+2.10% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XRAY($6.69B) has a higher market cap than PSNL($75.3M). PSNL YTD gains are higher at: -12.457 vs. XRAY (-15.415). XRAY has higher annual earnings (EBITDA): 249M vs. PSNL (-96.81M). XRAY has more cash in the bank: 334M vs. PSNL (114M). PSNL has less debt than XRAY: PSNL (47.7M) vs XRAY (2.3B). XRAY has higher revenues than PSNL: XRAY (3.97B) vs PSNL (73.5M).
PSNLXRAYPSNL / XRAY
Capitalization75.3M6.69B1%
EBITDA-96.81M249M-39%
Gain YTD-12.457-15.41581%
P/E RatioN/A19.23-
Revenue73.5M3.97B2%
Total Cash114M334M34%
Total Debt47.7M2.3B2%
FUNDAMENTALS RATINGS
PSNL vs XRAY: Fundamental Ratings
PSNL
XRAY
OUTLOOK RATING
1..100
1570
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
3
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9494
PRICE GROWTH RATING
1..100
3556
P/E GROWTH RATING
1..100
10087
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (3) in the Medical Specialties industry is somewhat better than the same rating for PSNL (36) in the null industry. This means that XRAY’s stock grew somewhat faster than PSNL’s over the last 12 months.

XRAY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as PSNL (100) in the null industry. This means that XRAY’s stock grew similarly to PSNL’s over the last 12 months.

XRAY's SMR Rating (94) in the Medical Specialties industry is in the same range as PSNL (94) in the null industry. This means that XRAY’s stock grew similarly to PSNL’s over the last 12 months.

PSNL's Price Growth Rating (35) in the null industry is in the same range as XRAY (56) in the Medical Specialties industry. This means that PSNL’s stock grew similarly to XRAY’s over the last 12 months.

XRAY's P/E Growth Rating (87) in the Medical Specialties industry is in the same range as PSNL (100) in the null industry. This means that XRAY’s stock grew similarly to PSNL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PSNLXRAY
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
56%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
58%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 5 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
PSNL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AGQ47.053.09
+7.03%
ProShares Ultra Silver
LCLG54.270.84
+1.58%
Logan Capital Broad Innovative Gr ETF
PEMX55.21N/A
N/A
Putnam Emerging Markets Ex-China ETF
DIHP29.37-0.02
-0.07%
Dimensional International High Pbly ETF
MVT10.05-0.03
-0.30%
Blackrock Munivest Fund II

PSNL and

Correlation & Price change

A.I.dvisor indicates that over the last year, PSNL has been loosely correlated with ISRG. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PSNL jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PSNL
1D Price
Change %
PSNL100%
-1.75%
ISRG - PSNL
35%
Loosely correlated
+0.02%
XRAY - PSNL
34%
Loosely correlated
-1.30%
CLPT - PSNL
33%
Loosely correlated
-1.08%
SYK - PSNL
33%
Loosely correlated
+0.14%
BLFS - PSNL
32%
Poorly correlated
-2.41%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
-1.30%
NVST - XRAY
53%
Loosely correlated
-0.37%
QDEL - XRAY
49%
Loosely correlated
-3.80%
ALGN - XRAY
48%
Loosely correlated
+0.20%
STE - XRAY
47%
Loosely correlated
+0.61%
KIDS - XRAY
45%
Loosely correlated
+3.63%
More